Recalls and Safety Alerts: Serious Fungal Infections with Humira, Cimzia, Enbrel and Remicade The manufacturers of Humira (adalimumab), Cimzia (certolizumab pegol), Enbrel (etanercept), and Remicade (infliximab) must strengthen warnings about the risk of developing opportunistic fungal infections from these drugs. These infections have been ...
# posted by Network @ 9:00 PM